Catherine Muller, Caroline Dusseau, Patrick Calsou and Bernard Salles

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Catherine Muller, Caroline Dusseau, Patrick Calsou and Bernard Salles"

Transcription

1 Oncogene (1998) 16, 1553 ± Stockton Press All rights reserved 0950 ± 9232/98 $12.00 Human normal peripheral blood B-lymphocytes are de cient in DNA-dependent protein kinase activity due to the expression of a variant form of the Ku86 protein Catherine Muller, Caroline Dusseau, Patrick Calsou and Bernard Salles Institut de Pharmacologie et de Biologie Structurale (CNRS, UPR 9062) 205 route de Narbonne, Toulouse cedex, France The heterodimeric Ku protein, which comprises a 86 kda (Ku86) amd a 70 kda (Ku70) subunits, is an abundant nuclear DNA-binding protein which binds in vitro to DNA termini without sequence speci city. Ku is the DNA-targeting component of the large catalytic sub-unit of the DNA-dependent protein kinase complex (DNA- PK CS ), that plays a critical role in mammalian doublestrand break repair and lymphoid V(D)J recombination. By using electrophoretic mobility shift assays, we demonstrated that in addition to the major Ku DNA complex usually detected in cell line extracts, a second complex with faster electrophoretic mobility was observed in normal peripheral blood lymphocytes (PBL) extracts. The presence of this faster migrating complex was restricted to B cells among the circulating lymphocyte population. Western blot analysis revealed that B cells express a variant form of the Ku86 protein with an apparent molecular weight of 69 kda, and not the 86 kda- full-length protein. Although the heterodimer Ku70/variant-Ku86 binds to DNA-ends, this altered form of the Ku heterodimer has a decreased ability to recruit the catalytic component of the complex, DNA-PK CS, which contributes to an absence of detectable DNA-PK activity in B cells. These data provide a molecular basis for the increased sensitivity of B cells to ionizing radiation and identify a new mechanism of regulation of DNA-PK activity that operates in vivo. Keywords: DNA-PK; Ku autoantigen; B-lymphocytes; V(D)J recombination Introduction Ku protein was originally identi ed as an autoantigen recognized by sera from patients with autoimmune diseases (Minori et al., 1981). Ku antigen was puri ed by immunoa nity and shown to be a heterodimer consisting of 86 kda (Ku86) and 70 kda (Ku70) subunits (Francoeur et al., 1986; Minori and Hardin, 1986). Biochemical analyses of Ku demonstrated that it bound in vitro to DNA termini or other discontinuities in the DNA structure without apparent sequence speci city (Minori and Hardin, 1986; Blier et al., 1993; Falzon et al., 1993). Ku has also been shown to possess DNA-dependent ATPase (Cao et al., 1994) and Correspondence: B Salles Received 27 August 1997; revised 24 October 1997; accepted 24 October 1997 helicase (Tuteja et al., 1994) activities. Lastly, Ku has also been reported to be capable of sequence-speci c binding within the promoter elements of genes (Gri n et al., 1996). Taken together, these biochemical properties have suggested a role for Ku in DNA metabolic processes such as recombination, repair, replication and/or transcription. It is now established that Ku is the DNA-targetting component of the DNA-dependent protein kinase (DNA-PK) complex. DNA-PK consists of the heterodimeric Ku protein and a large catalytic subunit (DNA PK CS ), a 460 kda serine/threonine kinase which belongs to the phosphatidyl (PI)-3 kinase (p110) family (Hartley et al., 1995). DNA-PK CS is recruited to DNA by Ku binding (Gottlieb and Jackson, 1993) and then acquires the capacity, at least in vitro, to phosphorylate many DNA-bound proteins in the vicinity (Anderson et al., 1994). Recently, a series of mutational and biochemical experiments have identi- ed DNA-PK as a crucial component of the mammalian double-strand breaks (DSBs) repair apparatus. Indeed, cell mutants with a defective Ku86 (CHO xrs cells) are sensitive to ionizing radiation (IR S ) due to a decreased ability to repair DSBs (for review see Jeggo, 1997). In xrs cells, a direct consequence of the Ku defect is a concomitant de ciency in the kinase activity of DNA-PK (Finnie et al., 1995) indicating that Ku DNA-binding represents the predominant, if only, mechanism for DNA-PK activation. Similarly, in the rodent scid and V-3 mutants, the loss of DNA- PK CS (Blunt et al., 1995; Peterson et al., 1995; Blunt et al., 1996; Danska et al., 1996) confers IR S and a de ciency in DNA DSBs repair (Biederman et al., 1991; Hendrickson et al., 1991). In addition to IR S, the observed defect in DNA DSB repair alters e cient joining of V(D)J recombination intermediates that result in a profound immunode ciency. The V(D)J recombination is a lymphoid and site-speci c DNA recombination process that assembles the non contiguous genomic segments that encode the Variable (V), Diversity (D), and Joining (J) elements of immunoglobulin and T cell receptor genes (reviewed in Weaver, 1995). Thus, mice homozygous for the murine severe combined immune de ciency (scid) mutation lack mature T- and B-lymphocytes, due to a defect in V(D)J recombination coding junction formation (Schuller et al., 1986). Lastly, knock-out mice for Ku86 have been generated and, as expected, these mice have a profound immunode ciency (Zhu et al., 1996). Although its precise role remains largely unknown, these results clearly identi ed DNA-PK as an essential component of the mammalian DNA repair apparatus that rejoin damage-induced, as well as V(D)J recombination intermediates, DSBs.

2 1554 In human cell lines, Ku represents the major doublestrand DNA end binding protein as detected by band shift experiments and its expression does not appear to be regulated within cell types (Finnie et al., 1996 and our unpublished results). In addition, in human lymphoblastoid cell lines, no changes in the levels of Ku polypeptides have been detected following treatment with ionizing radiation (Jongmans et al., 1996). All these results lead to the idea that Ku activity is present at high constitutive levels in human cells. Despite many studies performed with established cell lines, little is known about Ku activity in normal fresh human cells and tissues. Indeed, only a few studies of Ku gene expression have been reported to date (Yaneva and Jhiang, 1991; Cai et al., 1994). Regarding the major role of the Ku protein in DSBs repair, this appears to be an important question. In an attempt to explore this issue, we have chosen to study Ku function in normal peripheral blood lymphocytes (PBL) obtained from healthy donors. Our results show, for the rst time, that DNA-PK activity is regulated in vivo, through the expression of a variant form of the Ku86 protein in human normal B cells. Results CMulleret al Detection of an altered form of the Ku heterdomer in peripheral blood lymphocytes In human cell lines, Ku DNA-ends binding (DEB) activity can be easily detected by using dsdna fragments in an electrophoretic mobility shift assay (EMSA) (Zhang and Yanera, 1992). As shown in Figure 1, in the human cell lines AHH1 and HeLa, at least three complexes of di erent mobility were observed (A, A' and A''). Ku has the ability to translocate internally on DNA allowing another Ku heterodimer to bind to free DNA ends (devries et al., 1989). Thus, the increase in complex A' and A'' formation in association with increased protein concentration is likely to correspond to the binding of multiple Ku heterodimers to the same DNA-probe as previously described (Zhang and Yaneva, 1992). When PBL extracts were considered, the results consistently showed two features independent of the origin of the samples tested (shown for three di erent donors in Figure 1). Firstly, DEB activity appears lower in PBL extracts than the one observed for established cell lines. Secondly, in addition to the major complex usually detected in cell lines (complex A), a second complex with faster electrophoretic mobility (complex B) was observed in PBL extracts. In PBL, the signal due to these two di erent complexes appeared almost identical. This pro le of DEB activity was detected in all the PBL extracts tested in our laboratory (obtained to date from six di erent healthy donors). In our hands, this unusual pattern of DEB activity observed in PBL was not detected in a variety of transformed cell lines of human or rodent origin tested (data not shown). The pattern of DEB activity observed in PBL suggests either that an additional protein, expressed only in this cell population, is able to recognize double-stranded DNA-ends or that the Ku heterodimer is present in an altered form in PBL extracts. To test these two Extracts 2 µg 4 µg A" A' A F PBL PBL A H A H Figure 1 A second protein-dna ends complex with faster electrophoretic mobility is detected in PBL extracts. Increasing concentrations of protein extracts obtained from human cell lines (A, AHH1; H, HeLa) or PBL (three independent healthy donors) were incubated with 0.1 ng 32 P-labeled DNA probe in the presence of 1 mg of closed circular plasmid DNA, as a non speci c competitor. The electrophoretic mobility of the protein- DNA complexes were analysed in 5% polyacrylamide gel as described in Materials and methods. F, position of free DNA probe; A, A', A'' and B, positions of protein-dna complexes consisting of DNA-ends binding activity hypotheses, we rst evaluated the presence or absence of Ku70 and Ku86 proteins in the B complex, by using various antibodies directed against these proteins in EMSA supershift experiments. First, the autoantibodies (puri ed from the AF human serum), which were shown to recognize the Ku70 and Ku86 proteins (Francoeur et al., 1986), were used. In the presence of these antibodies, both A and B complexes were completely supershifted and retarded in the gel as shown in Figure 2 (panel I). Similar experiments were performed with antibodies directed either against Ku70 or Ku86, to further assess the presence in the B complex of each subunit of the Ku herodimer. For Ku86, two di erent antibodies were used: a polyclonal antibody, Ku86 pc, and mab S10B1 which recognizes an epitope de ned by aa 8 ± 221 on the N terminus of Ku86 (Wang et al., 1993). As shown in Figure 2 (panel II and III), all Ku antibodies supershifted the migration of the complex B present in PBL extracts and the migration of the complex A present in PBL and AHH1 extracts shown as a control. The mab S10B1 a ected the migration of the complex B less than the other Ku Abs (see Figure 2, panel III). However similar results were obtained for the complex A present in PBL and in AHH1 extracts suggesting that this lower reactivity is an inherent property of this antibody. Thus, this set of experiments showed that both Ku70 and Ku86 were present in the complex B, the faster migration pattern indicating that one or both Ku proteins are present in an altered/modi ed form in PBL extracts. The detection of the altered form of the Ku heterodimer is associated with B-lymphocyte population In PBL extracts, both forms of the Ku DNA complexes were detected by EMSA. Thus, the appearance of the faster migrating complex might be B

3 C Muller et al 1555 AHH1 PBL AHH1 PBL AHH1 PBL AF Abs (µg) C C C pc C pc C pc S10B1 C pc S10B1 Supershift A B F Ku 80/Ku 70 Ku 70 Ku 86 I II III Figure 2 EMSA supershift experiments demonstrate that the faster migrating complex contained both Ku70 and Ku86 proteins. 4 mg of whole cell extracts were incubated with 0.1 ng 32 P-labeled DNA probe in the presence of 1 mg of closed circular plasmid DNA, as a non speci c competitor. After 10 min, either no antibody (control) or antibodies speci c for (I) Ku70 and Ku86 proteins (mabs AF), (II) Ku70 protein (Ab Ku70 pc), (III) Ku86 protein, polyclonal (Ab Ku86 pc), or monoclonal that recognizes aa 8 ± 221 (mab S10B1) were added to the reaction mixture prior to gel electrophoresis. The electrophoretic mobility of the protein-dna complexes were analysed in 5% polyacrylamide gel as described in Materials and methods. F, position of free DNA probe; positions of protein-dna complexes consisting of DNA-ends binding activity and the region where the supershifted complexes migrate are indicated component of one of the sub-populations present in PBL. Indeed, when whole cell extracts from puri ed B cells were evaluated, only the faster migrating B complex was detected (Figure 3). Interestingly, in B cell extracts, the mobility change associated with increasing protein concentration was also observed (detection of two additional complexes B' and B'' when the protein concentration in the binding assay is 4 mg, Figure 3) suggesting that the altered form of the Ku heterodimer still has the ability to translocate on the DNA as previously described for the normal Ku protein (devries et al., 1989). In this representative experiment, the DEB activity is shown in proteins extracts obtained from the whole lymphocyte population and B cells, within the same blood sample. Furthermore, in one sample, we veri ed that in T cells the usual pattern of Ku DEB activity is detected (data not shown). Thus, these results showed that the presence of the faster migrating complex is largely con ned to B cells among the circulating lymphocyte population. The B-lymphocytes express a variant form of the Ku86 protein To further characterize the altered form of the Ku heterodimer, the expression of the Ku proteins was analysed by Western blot. The expression of the full length Ku70 protein, which migrates at approximately 72 kda in SDS polyacrylamide gels, was detected in PBL and B cells at a slightly lower level of expression (about twofold) than in the human cell lines AHH1 and HeLa (Figure 4, panel I). In contrast, the expression of Ku86 protein was altered in the extracts obtained from lymphocytes (Figure 4, panel II and III). In PBL extracts, in addition to the full-length 86 kda protein, a second band, which cross-reacts with anti- Ku86 pc Ab appeared at a lower position corresponding to about 69 kda. This band was absent in extracts Extracts 2 µg 4 µg A" A' A F A PBL LB A PBL LB B" B' Figure 3 The detection of the faster migrating complex is restricted to B cells within circulating lymphocyte population. Increasing concentrations of protein extracts obtained from the human cell line AHH1 (A), PBL or puri ed B cells were incubated with 0.1 ng 32 P-labeled DNA probe in the presence of 1 mg of closed circular plasmid DNA, as a non speci c competitor. The electrophoretic mobility of the protein-dna complexes were analysed in 5% polyacrylamide gel as described in Materials and methods. F, position of free DNA probe; the positions of protein-dna complexes consisting of DNA-ends binding activity are indicated from AHH1 and HeLa cells. In B cells extracts, the full-length protein was not detected and only the lower 69 kda band appeared. These results were con rmed B

4 1556 CMulleret al using the mab S10B1. Again, the full-length Ku86 protein was undetectable in B cells and a lower band, present as a doublet (at approximately 69 and 71 kda, with a higher expression of the 69 kda protein), was detected in lymphocytes that was not present in AHH1 or HeLa cells (Figure 4, panel III). The altered form of the Ku heterodimer has a decreased ability to recruit DNA-PK CS that results in a failure to detect DNA-PK activity in B cells The Ku heterodimer is the DNA-binding component of DNA-PK, the catalytic activity of which is carried by a 460 kda protein, DNA-PK CS. We have shown that the altered Ku heterodimer retains its capacity to bind to DNA termini. We then investigated the capacity of the altered heterodimer to contribute, in the presence of ds-dna, to the formation of an active DNA-PK complex. First, the protein kinase activity of the complex was evaluated in lymphocytes and in B-puri ed cell population using the `pull-down' assay as previously described (Finnie et al., 1995). In this assay, only proteins able to bind to double-stranded DNA ends on cellulose beads are considered. Furthermore, the speci city for DNA-PK activity is ensured through the use of both a consensus substrate peptide issued from the sequence of the murine p53 and a mutated peptide which is a poor substrate for DNA-PK phosphorylation in vitro. By using this assay, a detectable amount of DNA-PK activity was found in PBL but at a signi cantly lower level than the one observed in the AHH1 and HeLa human cell lines (Figure 5). In B cell extracts, no detectable DNA-PK activity was found in the three independent samples tested. Thus, it can be deduced from these experiments that the DNA-PK activity detected in PBL was solely due to the T cells present in the PBL samples. We then evaluated by Western blot experiments the expression of DNA-PK CS in these di erent samples. As shown in Figure 5, both PBL and B cell puri ed population extracts contained DNA-PK CS, although at a level which appeared lower (about twofold) than in the AHH1 cell line. Thus, these results suggested that the altered form of the Ku heterodimer present in B cells is not able to recruit the catalytic sub-unit of the complex, DNA-PK CS. To test this hypothesis, the proteins associated with the double-stranded DNA cellulose beads were eluted and subjected to Western analyses. Beads which have been incubated with AHH1 or PBL extracts contained DNA-PK CS as shown in Figure 6. In contrast, beads incubated with B cell extracts lacked DNA-PK CS. Furthermore, proteins associated with beads from all the extracts contained the Ku proteins. Beads which have been incubated with AHH1 extracts contained full length Ku70 and Ku86 whereas beads incubated with B cell extracts contained 250 kda A PBL LB Figure 5 B-lymphocytes are de cient in DNA-PK activity. Extracts (50 mg) were analysed by the DNA-PK pull-down assay in the presence of wild-type (black squares) or mutated (hatched squares) p53 peptide as indicated in Materials and methods. The established cell lines corresponded to AHH1 and HeLa cells. PBL extracts were obtained from three independent donors and B cell extracts from the puri ed B population of these three same samples. Mean of at least two experiments for all these independent extracts. The insert shows the expression of DNA- PK CS in these di erent cells as determined by Western blot experiments using mab 18 ± 2 (I) Ab Ku70 pc A H PBL LB AHH1 PBL LB DNA-PK cs (Ab 18 4) (II) Ab Ku86 pc Ku70 (Ab Ku70 pc) (III) Ab S10B1 K 86 (Ab S10B1) Figure 4 Western blot analysis in lymphocyte extracts revealed the expression of a variant form of the Ku86 protein. 50 mg of protein extracts obtained from human cell lines (A, AHH1; H, HeLa), PBL or B cells were subjected to electrophoresis on a 8% SDS polyacrylamide gel under reducing conditions. The proteins were then blotted onto a nitrocellulose lter and expression of the Ku proteins were detected as indicated in Materials and methods with indicated antibodies that recognize either the Ku70 protein (I) or the Ku86 protein (II and III) Figure 6 The variant Ku heterodimer is unable to interact with DNA-PK CS. After incubation of the indicated protein extracts with ds-dna cellulose beads, the proteins bound to the beads were eluted as indicated in Materials and methods and subjected to electrophoresis on a 8% SDS polyacrylamide gel under reducing conditions. The proteins were then blotted onto a nitrocellulose lter and the expression of DNA-PK CS, Ku70 and Ku86 was detected by Western blots using the indicated antibodies

5 full-length Ku70 and only the variant form of Ku86 (see Figure 6). These results imply that the altered form of the heterodimer fails to interact with DNA-PK CS. Mechanism(s) that contribute(s) to the expression of the Ku86 variant protein To test if the variant form of the Ku86 protein arises from a spliced form of Ku86, Northern blot experiments were performed using a Ku86 cdna probe. As shown in Figure 7, in the control cell line AHH1, Ku86 probe hybridized to two mrnas of 2.6 and 3.4 kb as previously described (Cai et al., 1994; Jongmans et al., 1996). The two Ku86 transcripts were also present in PBL and in puri ed B-lymphocytes and no smaller form of Ku86 mrna was detected in B-lymphocytes. Discussion In this study, we demonstrate that the Ku DNA-end binding activity is altered in peripheral blood B-lymphocytes with the expression of a faster mobility complex in electrophoretic mobility shift assays (EMSAs), as compared with human cell lines. Western blot analysis revealed that B cells express a variant form of the Ku86 protein with an apparent molecular weight of 69 kda, and not the 86 kda- full-length protein. Although the heterodimer Ku70/variant-Ku86 binds to DNA-ends, this altered form of the Ku heterodimer has a decreased ability to recruit the catalytic component of the complex, DNA-PK CS, which contributes to an absence of detectable DNA-PK activity in B cells. Characteristics of the variant Ku86 protein The results obtained in our study strongly suggest that the protein detected in B-lymphocytes indeed corresponds to a variant form of Ku86 rather than an unrelated protein which cross-reacts with Ku86 antibodies. It has been reported that the active DNA end binding member of the heterodimer is likely to be Ku70 (Zhang and Yaneva, 1992). One study raised the possibility that Ku70 might carry out this DEB function in the absence of Ku86 (Wang et al., 1994) but this remains controversial (Gri th et al., 1992). Indeed, recent work using in vitro-translated Ku products clearly showed that full-length individual subunits are inactive for DEB activity indicating that heterodimer assembly precedes, and is necessary for 3.4 kb 2.6 kb H PBL LB LB Figure 7 Northern blot experiments. 5 mg of total RNA obtained from the control cell line AHH1 (H), peripheral blood lymphocytes (PBL) or B-lymphocytes (LB, two independent healthy donors) were separated on a 1.2% agarose ± 7% formaldehyde gel, transferred to nitrocellulose and hybridized with a Ku86 cdna probe. The size of the two Ku86 mrnas transcripts detected is indicated C Muller et al DNA-binding (Wu et al., 1996). Thus, since Ku86 fulllength protein is undetectable in B-lymphocytes, it appears that the second band detected by the Western blot experiments is indeed a variant form of the Ku86 protein which results in DEB activity by the assembly with Ku70 protein. Similar expression of a variant form of the Ku86 protein (but in addition to the full-length protein) has been recently reported in the promyelocytic leukemia cell line, HL60 (Han et al., 1996). The variant form of the Ku86 protein detected in B-lymphocytes presents similarities with the protein detected in HL60 cell line. In both studies, the mab S10B1 (aa 8 ± 221) detected a doublet consisting of two lower forms of the Ku86 protein with apparent molecular weight of 69 and 71 kda. In the HL60 cell line, another mab which recognizes the 610 ± 705 aa of Ku86 (mab 111) failed to recognize the variant form of the protein. Interestingly, in a previous report, only the full-length Ku86 was detected in PBL using this antibody (Ajmani et al., 1995), suggesting that mab 111 also fails to recognize the Ku86 variant expressed in lymphocytes. Finally, we observed that mab 150 which recognizes an epitope within amino acid 490 to 707 of the Ku86 protein (Kamiya Biomedical Co, Seattle, Washington, USA) did not a ect the migration of the altered Ku heterodimer DNA complexes in EMSA supershift experiments (data not shown). At the present time, the domain(s) responsible for the interaction between Ku86 or the Ku heterodimer with the catalytic component of the DNA-PK CS complex remain(s) unknown. The inability of the mab 111 (aa 610 ± 705) to recognize the variant form of Ku86 in the HL60 cell line (Han et al., 1996) and in PBL (Ajmani et al., 1995) and of the mab 150 (aa 490 ± 707) to supershift Ku70/variant Ku86 DNA complexes (our results) may implicate the C-terminal part of the protein in this function. However, only reconstitution studies with various deletion mutants of the Ku86 protein will allow this question to be answered since conformational changes induced in the Ku86 variant (and not the region deleted) can be discounted for the decreased ability to recruit DNA-PK CS. Presently, the mechanism which contributes to the expression by B cells of this variant form of Ku86 remains unknown. This expression appeared however to result from a signi cant biological event occurring within the cells. The possibility that a nonspeci c proteolytic cleavage of Ku86 may have occurred during preparation of cell extracts can be ruled out since, (i) the expression of the variant form of Ku86 was observed in extracts from circulating blood lymphocytes and not from continuous human cell lines, even when the extract preparations were performed simultaneously; (ii) a large set of protease inhibitors was used during protein extraction (see Material and methods) that consistently would abrogate the cleavage events induced by the major classes of known proteases; (iii) it has been previously demonstrated that unstimulated B cells have low protease activity as compared to mitogen-activated cells (Kishi et al., 1983; Ku et al., 1983). Finally, our results suggest that the mechanism that contributes to the expression of the variant Ku86 protein occurs at the post-transcriptional level. Indeed, the fact that B-lymphocytes express the two Ku86 transcripts also detected in cell lines (Cai et al., 1994; 1557

6 1558 CMulleret al Jongmans et al., 1996 and our present results), and not a smaller form, strongly suggests that the variant Ku86 protein does not arise from a spliced form of Ku86 and favor the involvement of event such as speci c proteolysis. Implication of the absence of DNA-PK activity for DNA DSB repair activity in B cell lymphocytes The catalytic component of the DNA-PK complex is essential for DNA DSB repair activity. Indeed, mutant cell lines such as the hamster V-3 and the murine scid cell line that exhibited normal levels of Ku-DNA ends binding activity but are defective in the catalytic subunit, DNA-PK CS (Blunt et al., 1995; Peterson et al., 1995) show a defect in DSB repair after exposition to ionizing radiation. Interestingly, among normal fresh human cells, resting peripheral blood lymphocytes (PBL) are especially sensitive to IR and within subpopulations of lymphocytes, B cells are more sensitive than T cells (Prosser, 1976; Prusek and Astaldi, 1979; Schwartz and Gaulden, 1980). This relative radiosensitivity appears to be related to a defect in DNArepair capacity of these cells, especially in the rejoining of DSB (Mayer et al., 1986). In accordance with the major functional role of DNA-PK in DSBs repair, the observed defect in DNA-PK activity in our study provides a molecular basis for the increased sensitivity of B cells to ionizing radiation. Furthermore, since T cells, on the contrary, appear to contain detectable levels of DNA-PK activity (see Figure 5 and comments), our data may explain the known di erence in sensitivity towards IR between these two lymphocyte sub-populations. Besides lymphocytes, di erences in radiosensitivity are observed in cells derived from di erent tumor types, as well as in normal tissues within and between individuals. The molecular mechanism responsible for these di erences are not well understood (McMillan and Peacock, 1994). The level of DNA-PK activity is likely to play a role in this variation in radiosensitivity, as we have shown here for normal lymphocytes. The expression of the Ku86 variant protein may be important for the regulation of DNA-PK activity in vivo and studies of its expression and distribution amongst primary normal human cell and tissues may help to further understand the physiological mechanism(s) underlying the relative radiosensitivity in humans. Role of the Ku86 variant in B cell di erentiation Finally, our results suggest that DNA-PK activity is regulated during B cell di erentiation in a stage speci c manner, through the expression of a truncated form of the Ku86 protein. Indeed, V(D)J recombination occurs at de ned stages of lymphocyte development and this function is primarily regulated by the expression of the two recombination activating genes, RAG1 and RAG2 (for review see Weaver et al., 1995). Whether or not the expression and activity of DNA-PK holoenzyme is also actively regulated in human cells upon di erentiation and V(D)J rearrangement still remains unknown. However, the fact that DNA-PK is an essential component of the V(D)J recombination process suggests that this activity is present in actively recombining pro/pre-b cells in contrast to its absence observed in our study in unstimulated circulating B- lymphocytes. In the light of di erences in DNA-PK activity between circulating B and T cells observed in our study, it is interesting to note that recently published works underline unsuspected di erences in the molecular regulation of early B and T cell di erentiation, leading to the idea that partial bypass of DNA-PK-dependent pathway of DSBs rejoining may occur in the T cell, but not the B cell, lineage. Indeed, a single treatment of newborn scid mice with DNA-damaging agents restored functional, diverse T cell receptor b chain coding joints, as well as development and di erentiation of thymocytes, but did not promote B cell development (Danska et al., 1994). In addition, p53 de ciency promoted T cell development but did not appear to circumvent the block in B cell maturation conferred by the scid mutation (Guidos et al., 1996; Nacht et al., 1996). All these data provide evidence that the later steps involved in V(D)J joining are not regulated identically, in T and B cells. Thus, whether the relative expression of the variant form of Ku86 protein is used by human B cells to actively regulate DNA-PK activity upon di erentiation and V(D)J rearrangement appears an important issue. In conclusion, we have shown that DNA-PK activity is negatively regulated in normal circulating B cells through an original mechanism that involves the expression of a variant form of the Ku86 protein. Whether the expression of this variant protein is restricted to B cells amongst primary human cells and tissues, and the molecular mechanism that contributes to its expression, appears to give rise to two important issues that are currently investigated in our laboratory. Materials and methods Antibodies Monoclonal antibodies directed against Ku86 (mab S10B1, Interchim, France) and DNA-PK CS (mab 18 ± 2, provided by Dr T Carter, St-John's University, New York, USA) have been previously described (Wang et al., 1993; Carter et al., 1990). Polyclonal antibodies directed against Ku86 and Ku70 (designated Ku86 pc and Ku70 pc in our study) were provided by Dr Falaschi (UNIDO, Trieste, Italy) (Tuteja et al., 1994); Human serum (AF) that contained autoantibodies that cross-reacted with Ku70 and Ku86 antigens (Francoeur et al., 1986) were provided by Dr EM Tan (the Scripps Research Institute, La Jolla, USA) and puri ed antibodies were obtained in our laboratory by the protein A sepharose procedure. Peripheral blood lymphocytes and transformed cell lines Blood samples (50 to 100 ml) were collected in heparinized tubes from healthy consenting volunteers. Mononuclear cell suspensions were obtained after Hypaque- Ficoll (MSL, Eurobio, France) gradient centrifugation as previously described (Barret et al., 1995). Mononuclear cells at the interface were collected, diluted to cells/ ml in RPMI 1640 medium, and incubated in tissue culture asks for 2 h at 378C to remove monocytes by adherence. After monocyte depletion, the samples were divided into two parts. The rst part of the sample was used for immediate cell extract preparation of the whole lymphocyte

7 population (PBL). The second part of the sample was processed to obtain puri ed B cell suspension as follows: samples were incubated with antibody to CD3 (mab UCHT1, Dako, Trappes, France) and T cells then removed by incubation with goat anti-mouse IgG1 (Fc) antibody coupled to magnetic beads according to the manufacturer's recommendation (Dynabeads M-450, Dynal, Oslo, Norway). Under these conditions, less than 0.5% CD3 or CD14 positive cells were detected in the highly puri ed CD 19+ B cell population (data not shown). Cell viability was 490% by trypan blue exclusion. Following puri cation, B-lymphocytes were immediately used for cell extract preparation or RNA extraction. The Epstein-Barr virus immortalized human lymphoblastoid AHH1 and the human HeLa cell lines were grown in RPMI 1640 medium (Gibco BRL, Cergy Pontoise, France) supplemented with 10% fetal calf serum, 2 mm glutamine, 125 U/ml penicillin, and 125 mg/ml streptomycin. Cell extracts Whole cell extracts were prepared as previously described with slight modi cations (Finnie et al., 1995). Brie y, cells were resuspended in extraction bu er ( cells per 100 ml for transformed cell lines and cells per 100 ml for normal human lymphocytes) containing 50 mm NaF, 20 mm HEPES (ph 7.8), 450 mm NaCl, 25% glycerol, 0.2 mm EDTA, 0.5 mm dithiothreitol in the presence of proteinase inhibitors [0.5 mm phenylmethylsulfonyl fluoride, 0.5 mg/ml apoprotin, 0.5 mg/ml chymostatin, 0.5 mg/ml leupeptin and 1.5 mg/ml pepstatin], then frozen on dry ice and thawed at 308C three times. After centrifugation for 30 min at 48C, supernatants were stored at 7708C. Band shift assay The probe was prepared as follows: an aliquot of a 123-bp DNA ladder (Gibco BRL, France) was digested with AvaI (Gibco BRL, Cergy Pontoise, France) in order to generate 123 bp monomers. After puri cation from agarose gel, fragments were end-labeled with a- 32 P-dCTP using DNA polymerase I Klenow fragment (Gibco BRL, France). Endlabeled probes were separated from unincorporated nucleotides by chromatography through Sephadex G-50 (Sigma, Saint Quentin, France). The band shift assay was performed as previously described (Zhang and Yaneva, 1992). In the supershift experiments, antibodies (at the indicated concentration) were added to the reaction mixture following 10 min incubation at 308C and incubated for an additional 20 min prior to gel electrophoresis. C Muller et al Western blot Proteins were subjected to electrophoresis on a 8% SDS ± polyacrylamide gel under reducing conditions. The proteins were then electroblotted onto a nitrocellulose lter using a semi-dry apparatus (Bio-Rad Trans-Blot, Bio-Rad, Ivrysur-Seine, France). Western blot experiments were performed as previously described (Muller et al., 1994). Antibodies used in Western-blotting experiments were as follows: the polyclonal antibodies directed against Ku70 and Ku80 proteins were used at a 1 : 2500 dilution (secondary antibody mouse anti-rabbit at a 1 : 2500 dilution). The puri ed monoclonal antibody directed against Ku86 (mab S10B1) was used at a 1 : 1000 dilution and the anti DNA-PK CS antibody 18 ± 2 at a 1 : 5000 dilution (secondary antibody goat anti-mouse at a 1 : 2500 and 1 : 5000 dilution, respectively). DNA-PK assay DNA-PK `pulldown' kinase assay was performed as previously described (Finnie et al., 1995). In certain experiments, after incubation of the extracts with doublestranded DNA-cellulose beads (Sigma, Saint-Quentin, France), beads were extensively washed with Z' 0.05 bu er [25 mm HEPES (ph 7.9), 50 mm KCl, 10 mm MgCl2, 20% glycerol, 0.1% Nodinet P-40, 1 mm dithiothreitol] and incubated for 1 h in 50 mm Tris-HCl ph 9.0/ Triton 1% with constant agitation to elute proteins bound to the beads. Samples were then electrophoresed in an 8% SDS ± polyacrylamide gel under reducing conditions. Proteins were transferred onto nitrocellulose lters which were subjected to Western blot analysis for the presence of DNA-PK CS, and Ku proteins as indicated above. Northern blotting Total RNA was isolated from lymphocytes and control cell line (AHH1) using TRIZOL reagent (GIBCO BRL) according to the manufacturer's recommendation. Five to 10 mg of RNA were then separated on a 1.2% agarose ± 7% formaldehyde gel. RNA was transferred to nitrocellulose and hybridized as previously described (Muller et al., 1994) using a Ku86 cdna probe (from nucleotide 248 to nucleotide 1198). Before hybridization experiments the transfer membranes were photographed under U.V. light to assess the amount of rrna by ethidium bromide uorescence. Acknowledgements The excellent technical assistance by Helene Vinial is gratefully acknowledged. We thank Dr Defais, Dr Jonhson (IPBS, Toulouse, France) for critical reading of the manuscript. We are grateful to Dr EM Tan for the gift of the AF serum, to Dr T Carter and Dr A Falaschi for the gift of the antibodies directed against DNA-PK CS and Ku proteins, respectively. This study was supported by grants from the `Association pour la Recherche sur le Cancer', the `Ligue Nationale Contre le Cancer' and the `Fondation de France'. CM is a recipient of a post-doctoral fellowship from the `Comite leuceâ miedelafondationdefrance' References Ajmani AK, Satoh M, Reap E, Cohen PL and Reeves WH. (1995). J. Exp. Med., 181, 2049 ± Anderson CW, Connelly MA, Zhang H, Sipley JD, Leesmiller SP, Sakaguchi K, Ullrich SJ, Jackson SP and Appella E. (1994). J. Protein Chem., 13, 500 ± 501. Barret JM, Calsou P and Salles B. (1995). Carcinogenesis, 7, 1611 ± Biedermann KA, San JR, Giaccia AJ, Tosto LM and Brown JM. (1991). Proc. Natl. Acad. Sci. USA, 88, 1394 ± Blier PR, Gri th AJ, Craft J and Hardin JA. (1993). J. Biol. Chem., 268, 7594 ± Blunt T, Gell D, Fox M, Taccioli GE, Lehmann AR, Jackson SP and Jeggo PA. (1996). Proc. Natl. Acad. Sci. USA, 93, ± Blunt T, Finnie NJ, Taccioli GE, Smith GC, Demengeot J, Gottlieb TM, Mizuta R, Varghese AJ, Alt FW, Jeggo PA and Jackson SP. (1995). Cell, 80, 813 ± 823.

8 1560 CMulleret al Cai QQ, Plet AA, Imbert J, Lafagepochitalo M, Cerdan C and Blanchard JM. (1994). Cytogen. Cell. Genet., 65, 221 ± 227. Cao QP, Pitt S, Leszyk J and Baril EF. (1994). Biochemistry, 33, 8548 ± Carter T, Vancurova I, Sun I, Lou W and DeLeon S. (1990). Mol. Cell. Biol., 10, 6460 ± Danska JS, Holland DP, Mariathasan S, Williams KM and Guidos CJ. (1996). Mol. Cell. Biol., 16, 5507 ± Danska JS, P umio F, Williams CJ, Huner O, Dick JE, Guidos CJ. (1994). Science, 266, 450 ± 455. devries E, van Driel W, Bergsma WG, Arnberg AC and Van der Vliet PC. (1989). J. Mol. Biol., 208, 65 ± 78. Falzon M, Fewell JW and Ku EL. (1993). J. Biol. Chem., 268, ± Finnie NJ, Gottlieb TM, Blunt T, Jeggo PA and Jackson SP. (1995). Proc. Natl. Acad. Sci. USA, 92, 320 ± 324. Finnie NJ, Gottlieb TM, Blunt T, Jeggo PA and Jackson SP. (1996). Phil. Trans. Royal Soc., 351, 173 ± 179. Francoeur AM, Peebles CL, Gompper PT and Tan EM. (1986). J. Immunol., 136, 1648 ± Gi n W, Torrance H, Rodda DJ, Prefontaine GG, Pope L and Hache RJG. (1996). Nature, 380, 265 ± 268. Gottlieb TM and Jackson SP. (1993). Cell, 72, 131 ± 142. Gri th AJ, Blier PR, Minori T and Hardin JA. (1992). J. Biol. Chem., 267, 331 ± 338. Guidos CJ, Williams CJ, Grandal I, Knowles G, Huang MT and Danska JS. (1996). Genes & Dev., 10, 1054 ± Han Z, Johnston C, Reeves WH, Carter T, Wyche JH and Hendrickson E. (1996). J. Biol. Chem., 271, ± Hartley KO, Gell D, Smith GC, Zhang H, Divecha N, Connelly MA, Admon A, Leesmiller SP, Anderson CW and Jackson SP. (1995). Cell, 82, 849 ± 856. Henderickson EA, Qin XQ, Bump EA, Schatz DG, Oettinger M and Weaver DT. (1991). Proc. Natl. Acad. Sci. USA, 88, 4061 ± Jeggo PA. (1997). Mutation Res., 384, 1±14. Jongmans W, Artuso M, Vuillaume M, Bre sil H, Jackson SP and Hall J. (1996). Oncogene, 13, 1133 ± KishiH,MikiY,KikutaniH,YamamuraYandKishimoto T. (1983). J. Immunol., 131, 1961 ± Ku GS, Quigley JP and Sultzer BM. (1983). J. Immunol., 131, 2444 ± Mayer PJ, Bradley MO and Nichols WW. (1986). Mutation Res., 166, 275 ± 285. McMillan TJ and Peacock JH. (1994). Int. J. Radiat. Biol., 65, 49 ± 55. Minori T and Hardin JA. (1986). J. Biol. Chem., 261, ± Minori T, Akizuki M, Yamagata H, Inada S, Yoshida S and Homma M. (1981). J. Clin. Invest., 68, 611 ± 620. Muller C, Bailly JD, Goubin F, Laredo J, Ja rezou JP, Bordier C and Laurent G. (1994). Int. J. Cancer, 56, 749 ± 754. Nacht M, Strasser A, Chan YR, Harris AW, Schlissel M, Bronson RT and Jacks T. (1996). Gene & Dev., 10, 2055 ± Peterson SR, Kurimasa A, Oshimura M, Dynan WS, Bradbury EM and Chen DJ. (1995). Proc. Natl. Acad. Sci. USA, 92, 3171 ± Prosser JS. (1976). Int. J. Radiat. Biol., 30, 459 ± 465. Prusek W and Astaldi G. (1979). Arch. Immunol. Ther. Exp., 27, 59 ± 71. Schuller W, Weiler IJ, Schuller A, Phillips RA, Rosenberg N, Mak TW, Kearney JF, Perry RP and Bosma MJ. (1986). Cell, 46, 963 ± 972. Schwartz JL and Gaulden ME. (1980). Environ. Mutagen., 2, 473 ± 485. Tuteja N, Tuteja R, Ochem A, Taneja P, Huang NW, Simoncsits A, Susic S, Rahman K, Marusic L, Chen J, Zhang J, Wang S, Ponger S and Falaschi A. (1994). EMBO J., 13, 4991 ± Wang J, Chou CH, Blankson J, Satoh M, Knuth MW, Eisenberg RA, Pisetsky DS and Reeves WH. (1993). Mol. Biol. Rep., 18, 15 ± 28. Wang J, Satoh M, Chou CH and Reeves WH. (1994). FEBS Lett., 351, 219 ± 224. Weaver DT. (1995). Adv. Immunol., 58, 29 ± 84. Wu X and Lieber MR. (1996). Mol. Cell. Biol., 16, 5186 ± Yaneva M and Jhiang S. (1991). Biochim. Biophys. Acta, 1090, 181 ± 187. Zhang WW and Yaneva M. (1992). Biochem. Biophys. Res. Comm., 186, 574 ± 579. Zhu C, Bogue MA, Lim DS, Hasty P and Roth DB. (1996). Cell, 86, 379 ± 389.

scid Cells Are Deficient in Ku and Replication Protein A Phosphorylation by the DNA-Dependent Protein Kinase

scid Cells Are Deficient in Ku and Replication Protein A Phosphorylation by the DNA-Dependent Protein Kinase MOLECULAR AND CELLULAR BIOLOGY, Oct. 1995, p. 5700 5706 Vol. 15, No. 10 0270-7306/95/$04.00 0 Copyright 1995, American Society for Microbiology scid Cells Are Deficient in Ku and Replication Protein A

More information

Species predicted to react based on 100% sequence homology: Chicken, Bovine, Dog.

Species predicted to react based on 100% sequence homology: Chicken, Bovine, Dog. 1 of 5 11/1/2013 10:25 PM Product Pathways - Jak/Stat Pathway Phospho-Stat3 (Tyr705) Antibody #9131 Have you tried your application using our XP monoclonal antibodies? Try products: 9145 PhosphoSitePlus

More information

XactEdit Cas9 Nuclease with NLS User Manual

XactEdit Cas9 Nuclease with NLS User Manual XactEdit Cas9 Nuclease with NLS User Manual An RNA-guided recombinant endonuclease for efficient targeted DNA cleavage Catalog Numbers CE1000-50K, CE1000-50, CE1000-250, CE1001-250, CE1001-1000 Table of

More information

HiPer RT-PCR Teaching Kit

HiPer RT-PCR Teaching Kit HiPer RT-PCR Teaching Kit Product Code: HTBM024 Number of experiments that can be performed: 5 Duration of Experiment: Protocol: 4 hours Agarose Gel Electrophoresis: 45 minutes Storage Instructions: The

More information

SuperScript IV Reverse Transcriptase as a better alternative to AMV-based enzymes

SuperScript IV Reverse Transcriptase as a better alternative to AMV-based enzymes WHITE PAPER SuperScript IV Reverse Transcriptase SuperScript IV Reverse Transcriptase as a better alternative to AMV-based enzymes Abstract Reverse transcriptases (RTs) from avian myeloblastosis virus

More information

Supplemental Online Material. The mouse embryonic fibroblast cell line #10 derived from β-arrestin1 -/- -β-arrestin2 -/-

Supplemental Online Material. The mouse embryonic fibroblast cell line #10 derived from β-arrestin1 -/- -β-arrestin2 -/- #1074683s 1 Supplemental Online Material Materials and Methods Cell lines and tissue culture The mouse embryonic fibroblast cell line #10 derived from β-arrestin1 -/- -β-arrestin2 -/- knock-out animals

More information

FMF NIRCA PROTOCOL STEP 1.

FMF NIRCA PROTOCOL STEP 1. FMF NIRCA PROTOCOL STEP 1. After you have isolated patient s DNA and DNA from a healthy donor (wild type), you perform a nested PCR. The primers used to amplify exon 2 and exon 10 of the mefv gene are

More information

Fisher (Fairlawn, NJ) and Sigma-Aldrich (St. Louis, MO) and were used without further. (Promega) and DpnI (New England Biolabs, Beverly, MA).

Fisher (Fairlawn, NJ) and Sigma-Aldrich (St. Louis, MO) and were used without further. (Promega) and DpnI (New England Biolabs, Beverly, MA). 175 Appendix III Chapter 4 Methods General. Unless otherwise noted, reagents were purchased from the commercial suppliers Fisher (Fairlawn, NJ) and Sigma-Aldrich (St. Louis, MO) and were used without further

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION A human XRCC4-XLF complex bridges DNA ends. Sara N. Andres 1, Alexandra Vergnes 2, Dejan Ristic 3, Claire Wyman 3, Mauro Modesti 2,4, and Murray Junop 2,4 1 Department of Biochemistry

More information

Antibody Structure. Antibodies

Antibody Structure. Antibodies Antibodies Secreted by B lymphocytes Great diversity and specificity: >10 9 different antibodies; can distinguish between very similar molecules Tag particles for clearance/destruction Protect against

More information

Antibody Structure supports Function

Antibody Structure supports Function Antibodies Secreted by B lymphocytes Great diversity and specificity: >10 9 different antibodies; can distinguish between very similar molecules Tag particles for clearance/destruction Protect against

More information

Ral Activation Assay Kit

Ral Activation Assay Kit Product Manual Ral Activation Assay Kit Catalog Number STA-408 20 assays FOR RESEARCH USE ONLY Not for use in diagnostic procedures Introduction Small GTP-binding proteins (or GTPases) are a family of

More information

A Model for Ku Heterodimer Assembly and Interaction with DNA

A Model for Ku Heterodimer Assembly and Interaction with DNA THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 273, No. 47, Issue of November 20, pp. 31068 31074, 1998 1998 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. A Model for

More information

WesternMAX Alkaline Phosphatase Chemiluminescent Detection Kits

WesternMAX Alkaline Phosphatase Chemiluminescent Detection Kits WesternMAX Alkaline Phosphatase Chemiluminescent Detection Kits Code N221-KIT N220-KIT Description WesternMAX Chemiluminescent AP Kit, Anti-Mouse Includes: Alkaline Phosphatase (AP) Conjugated Anti-Mouse

More information

Viral RNAi suppressor reversibly binds sirna to. outcompete Dicer and RISC via multiple-turnover

Viral RNAi suppressor reversibly binds sirna to. outcompete Dicer and RISC via multiple-turnover Supplementary Data Viral RNAi suppressor reversibly binds sirna to outcompete Dicer and RISC via multiple-turnover Renata A. Rawlings 1,2, Vishalakshi Krishnan 2 and Nils G. Walter 2 * 1 Biophysics and

More information

Eukaryotic Transcription

Eukaryotic Transcription Eukaryotic Transcription I. Differences between eukaryotic versus prokaryotic transcription. II. (core vs holoenzyme): RNA polymerase II - Promotor elements. - General Pol II transcription factors (GTF).

More information

SANTA CRUZ BIOTECHNOLOGY, INC.

SANTA CRUZ BIOTECHNOLOGY, INC. TECHNICAL SERVICE GUIDE: Western Blotting 2. What size bands were expected and what size bands were detected? 3. Was the blot blank or was a dark background or non-specific bands seen? 4. Did this same

More information

Technical Note Detection of post-immunoprecipitation proteins by Western blot using the Quick Western Kit IRDye 680RD

Technical Note Detection of post-immunoprecipitation proteins by Western blot using the Quick Western Kit IRDye 680RD Technical Note Detection of post-immunoprecipitation proteins by Western blot using the Quick Western Kit IRDye 680RD Developed for: Aerius, Odyssey Classic, Odyssey CLx and Odyssey Sa Imaging Systems

More information

IMMUNOGLOBULIN GENES UNDERGO TWO DNA REARRANGEMENTS

IMMUNOGLOBULIN GENES UNDERGO TWO DNA REARRANGEMENTS A Prototype Ig Gene: Murine Kappa About 10 0 V κ gene segments 4 J Gene Segment s 1 C κ Gene Segmen t Multiple V gene segments, distant from J and C A few J gene segments One C gene segment GERMLINE Ig

More information

western blotting tech

western blotting tech western blotting tech note 6148 Transfer of High Molecular Weight Proteins to Membranes: A Comparison of Transfer Efficiency Between Blotting Systems Nik Chmiel, Bio-Rad Laboratories, Inc., 6000 James

More information

Lecture Four. Molecular Approaches I: Nucleic Acids

Lecture Four. Molecular Approaches I: Nucleic Acids Lecture Four. Molecular Approaches I: Nucleic Acids I. Recombinant DNA and Gene Cloning Recombinant DNA is DNA that has been created artificially. DNA from two or more sources is incorporated into a single

More information

Non-Organic-Based Isolation of Mammalian microrna using Norgen s microrna Purification Kit

Non-Organic-Based Isolation of Mammalian microrna using Norgen s microrna Purification Kit Application Note 13 RNA Sample Preparation Non-Organic-Based Isolation of Mammalian microrna using Norgen s microrna Purification Kit B. Lam, PhD 1, P. Roberts, MSc 1 Y. Haj-Ahmad, M.Sc., Ph.D 1,2 1 Norgen

More information

DNA 5 End-Labeling System INSTRUCTIONS FOR USE OF PRODUCT U2010.

DNA 5 End-Labeling System INSTRUCTIONS FOR USE OF PRODUCT U2010. Technical Bulletin DNA 5 End-Labeling System INSTRUCTIONS FOR USE OF PRODUCT U2010. PRINTED IN USA. Revised 12/12 DNA 5 End-Labeling System All technical literature is available on the Internet at: www.promega.com/protocols/

More information

The preparation of native chromatin from cultured human cells.

The preparation of native chromatin from cultured human cells. Native chromatin immunoprecipitation protocol The preparation of native chromatin from cultured human cells. All solutions need to be ice cold. Sucrose containing solutions must be made up fresh on the

More information

Week 1: Protein isolation and quantification

Week 1: Protein isolation and quantification Week 1: Protein isolation and quantification Objective The objective of this lab exercise is to obtain protein samples from fruit fly larvae, BCS and FBS, all of which are then quantitated in the preparation

More information

Efficient Multi-site-directed Mutagenesis directly from Genomic Template.

Efficient Multi-site-directed Mutagenesis directly from Genomic Template. Efficient Multi-site-directed Mutagenesis directly from Genomic Template. Fengtao Luo 1, Xiaolan Du 1, Tujun Weng 1, Xuan Wen 1, Junlan Huang 1, Lin Chen 1 Running title: Multi-site-directed Mutagenesis

More information

Cdc42 Activation Assay Kit

Cdc42 Activation Assay Kit Product Manual Cdc42 Activation Assay Kit Catalog Number STA- 402 20 assays FOR RESEARCH USE ONLY Not for use in diagnostic procedures Introduction Small GTP-binding proteins (or GTPases) are a family

More information

Rho activation kit. Catalog Number: ADI-EKS-465. Table of Contents

Rho activation kit. Catalog Number: ADI-EKS-465. Table of Contents Rho activation kit Catalog Number: ADI-EKS-465 Table of Contents Assay Design Page 1 Scientific Overview 2 Precautions 2 Materials Provided 3 Storage of Materials 3 Materials Required but Not Provided

More information

Myers Lab ChIP-seq Protocol v Modified January 10, 2014

Myers Lab ChIP-seq Protocol v Modified January 10, 2014 Myers Lab ChIP-seq Protocol V011014 1 Contact information: Dr. Florencia Pauli Behn HudsonAlpha Institute for Biotechnology 601 Genome Way Huntsville, AL 35806 Telephone: 256-327-5229 Email: fpauli@hudsonalpha.org

More information

DNA Purification for Case Transgene Pronuclear Injection Updated 2/26/08 RM

DNA Purification for Case Transgene Pronuclear Injection Updated 2/26/08 RM DNA Purification for Case Transgene Pronuclear Injection Updated 2/26/08 RM Materials: Stratagene StrataPrep DNA Gel Extraction Kit (Catalog #400766 or #400768) http://www.stratagene.com/products/displayproduct.aspx?pid=448

More information

Supplemental Information. PARP1 Represses PAP and Inhibits Polyadenylation during Heat Shock

Supplemental Information. PARP1 Represses PAP and Inhibits Polyadenylation during Heat Shock Molecular Cell, Volume 49 Supplemental Information PARP1 Represses PAP and Inhibits Polyadenylation during Heat Shock Dafne Campigli Di Giammartino, Yongsheng Shi, and James L. Manley Supplemental Information

More information

Bio11 Announcements. Ch 21: DNA Biology and Technology. DNA Functions. DNA and RNA Structure. How do DNA and RNA differ? What are genes?

Bio11 Announcements. Ch 21: DNA Biology and Technology. DNA Functions. DNA and RNA Structure. How do DNA and RNA differ? What are genes? Bio11 Announcements TODAY Genetics (review) and quiz (CP #4) Structure and function of DNA Extra credit due today Next week in lab: Case study presentations Following week: Lab Quiz 2 Ch 21: DNA Biology

More information

The GeneEditor TM in vitro Mutagenesis System: Site- Directed Mutagenesis Using Altered Beta-Lactamase Specificity

The GeneEditor TM in vitro Mutagenesis System: Site- Directed Mutagenesis Using Altered Beta-Lactamase Specificity Promega Notes Magazine Number 62, 1997, p. 02 The GeneEditor TM in vitro Mutagenesis System: Site- Directed Mutagenesis Using Altered Beta-Lactamase Specificity By Christine Andrews and Scott Lesley Promega

More information

IMMUNOPRECIPITATION TROUBLESHOOTING TIPS

IMMUNOPRECIPITATION TROUBLESHOOTING TIPS IMMUNOPRECIPITATION TROUBLESHOOTING TIPS Creative Diagnostics Abstract Immunoprecipitation (IP) is the technique of precipitating a protein antigen out of solution using an antibody that specifically binds

More information

Solutions to Quiz II

Solutions to Quiz II MIT Department of Biology 7.014 Introductory Biology, Spring 2005 Solutions to 7.014 Quiz II Class Average = 79 Median = 82 Grade Range % A 90-100 27 B 75-89 37 C 59 74 25 D 41 58 7 F 0 40 2 Question 1

More information

Gene Expression Technology

Gene Expression Technology Gene Expression Technology Bing Zhang Department of Biomedical Informatics Vanderbilt University bing.zhang@vanderbilt.edu Gene expression Gene expression is the process by which information from a gene

More information

DNA Laddering Assay Kit

DNA Laddering Assay Kit DNA Laddering Assay Kit Item No. 660990 Customer Service 800.364.9897 * Technical Support 888.526.5351 www.caymanchem.com TABLE OF CONTENTS GENERAL INFORMATION 3 Materials Supplied 3 Precautions 4 If You

More information

This Document Contains:

This Document Contains: This Document Contains: 1. In-Cell Western Protocol II. Cell Seeding and Stimulation Supplemental Protocol III. Complete Assay Example: Detailing the Seeding, Stimulation and Detection of the A431 Cellular

More information

Supplemental Data. LMO4 Controls the Balance between Excitatory. and Inhibitory Spinal V2 Interneurons

Supplemental Data. LMO4 Controls the Balance between Excitatory. and Inhibitory Spinal V2 Interneurons Neuron, Volume 61 Supplemental Data LMO4 Controls the Balance between Excitatory and Inhibitory Spinal V2 Interneurons Kaumudi Joshi, Seunghee Lee, Bora Lee, Jae W. Lee, and Soo-Kyung Lee Supplemental

More information

TECHNICAL BULLETIN. JNK 1&2 Activity Assay Kit. Product Number CS0380 Storage Temperature 20 C

TECHNICAL BULLETIN. JNK 1&2 Activity Assay Kit. Product Number CS0380 Storage Temperature 20 C JNK 1&2 Activity Assay Kit Product Number CS0380 Storage Temperature 20 C TECHNICAL BULLETIN Product Description The c-jun N-terminal kinases (JNKs), also known as stress activated protein kinases (SAPKs),

More information

ab Ubiquitylation Assay Kit

ab Ubiquitylation Assay Kit ab139467 Ubiquitylation Assay Kit Instructions for Use For the activation of ubiquitin for use in ubiquitylation experiments This product is for research use only and is not intended for diagnostic use.

More information

P HENIX. PHENIX PCR Enzyme Guide Tools For Life Science Discovery RESEARCH PRODUCTS

P HENIX. PHENIX PCR Enzyme Guide Tools For Life Science Discovery RESEARCH PRODUCTS PHENIX PCR Enzyme Guide PHENIX offers a broad line of premium quality PCR Enzymes. This PCR Enzyme Guide will help simplify your polymerase selection process. Each DNA Polymerase has different characteristics

More information

Catalog No. SA-40002: 50 preparation SA-40001: 100 preparation

Catalog No. SA-40002: 50 preparation SA-40001: 100 preparation BDtract TM Genomic DNA Isolation Kit Instruction Manual Catalog No. SA-40002: 50 preparation SA-40001: 100 preparation Maxim Biotech, Inc. 780 Dubuque Avenue, So. San Francisco, CA 94080, U.S.A. Tel: (800)

More information

Mouse Factor XII Total ELISA Kit

Mouse Factor XII Total ELISA Kit Mouse Factor XII Total ELISA Kit Catalog No: IMFXIIKT-TOT Lot No: SAMPLE INTENDED USE This mouse coagulation Factor XII antigen assay is intended for the quantitative determination of total Factor XII

More information

Heat Shock Transcription Factor 1 Binds Selectively in Vitro to Ku Protein and the Catalytic Subunit of the DNA-dependent Protein Kinase*

Heat Shock Transcription Factor 1 Binds Selectively in Vitro to Ku Protein and the Catalytic Subunit of the DNA-dependent Protein Kinase* THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 272, No. 41, Issue of October 10, pp. 26009 26016, 1997 1997 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Heat Shock Transcription

More information

EXPERIMENT NINE: SOUTHERN BLOT

EXPERIMENT NINE: SOUTHERN BLOT EXPERIMENT NINE: SOUTHERN BLOT The objectives of this experiment are to: (1) restrict genomic DNA for Southern blot electrophoresis (2) electrophorese restricted gdna for Southern blotting (3) perform

More information

SensoLyte Anti-alpha-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) *Colorimetric*

SensoLyte Anti-alpha-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) *Colorimetric* Catalog # Kit Size SensoLyte Anti-alpha-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) *Colorimetric* AS-55550 One 96-well strip plate This kit is optimized to detect human/mouse/rat alpha-synuclein

More information

Learning Objectives. Define RNA interference. Define basic terminology. Describe molecular mechanism. Define VSP and relevance

Learning Objectives. Define RNA interference. Define basic terminology. Describe molecular mechanism. Define VSP and relevance Learning Objectives Define RNA interference Define basic terminology Describe molecular mechanism Define VSP and relevance Describe role of RNAi in antigenic variation A Nobel Way to Regulate Gene Expression

More information

A General Protocol for GST Pull-down Lili Jing *

A General Protocol for GST Pull-down Lili Jing * A General Protocol for GST Pull-down Lili Jing * Department of Cell and Molecular Biology, University of Pennsylvania, Philadelphia, USA *For correspondence: lilijingcn@gmail.com [Abstract] GST pull-down

More information

Kinase Reaction and Alkylation Protocol

Kinase Reaction and Alkylation Protocol Kinase Reaction and Alkylation Protocol Protocol for the treatment of substrates prior to detection by Thiophosphate Ester antibodies This product is for research use only and is not intended for diagnostic

More information

RayBio Phospho- Stat 3 (Tyr705) ELISA Kit

RayBio Phospho- Stat 3 (Tyr705) ELISA Kit RayBio Phospho- Stat 3 (Tyr705) ELISA Kit For Measuring Phosphorylated Stat3 (Tyr705) in Human, Mouse and Rat Cell Lysates User Manual (Revised Mar 1, 2012) RayBio Stat3 (Tyr705) ELISA Kit Protocol (Cat#:

More information

Store samples to be assayed within 24 hours at 2-8 C. For long-term storage, aliquot and freeze samples at -20 C. Avoid repeated freeze-thaw cycles.

Store samples to be assayed within 24 hours at 2-8 C. For long-term storage, aliquot and freeze samples at -20 C. Avoid repeated freeze-thaw cycles. Human Retinol Binding Protein 4, RBP4 ELISA Kit Preparation Plate Washing Discard the solution in the plate without touching the side walls. Blot the plate onto paper towels or other absorbent material.

More information

LECTURE: 22 IMMUNOGLOBULIN DIVERSITIES LEARNING OBJECTIVES: The student should be able to:

LECTURE: 22 IMMUNOGLOBULIN DIVERSITIES LEARNING OBJECTIVES: The student should be able to: LECTURE: 22 Title IMMUNOGLOBULIN DIVERSITIES LEARNING OBJECTIVES: The student should be able to: Identify the chromosome that contains the gene segments that encode the surface immunoglobulin heavy chain

More information

Ku Entry into DNA Inhibits Inward DNA Transactions in Vitro*

Ku Entry into DNA Inhibits Inward DNA Transactions in Vitro* THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 275, No. 46, Issue of November 17, pp. 35684 35691, 2000 2000 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Ku Entry into

More information

8/21/2014. From Gene to Protein

8/21/2014. From Gene to Protein From Gene to Protein Chapter 17 Objectives Describe the contributions made by Garrod, Beadle, and Tatum to our understanding of the relationship between genes and enzymes Briefly explain how information

More information

Note: for laboratory research use only. RNA High-purity Total RNA Rapid Extraction Kit (Spin-column) Signalway Biotechnology

Note: for laboratory research use only. RNA High-purity Total RNA Rapid Extraction Kit (Spin-column) Signalway Biotechnology Note: for laboratory research use only RNA High-purity Total RNA Rapid Extraction Kit (Spin-column) Cat. #: RP1202 (50preps) Signalway Biotechnology I. Kit Content, Storage Condition and Stability Content

More information

RayBio Phospho- Akt (Ser473) ELISA Kit

RayBio Phospho- Akt (Ser473) ELISA Kit RayBio Phospho- Akt (Ser473) ELISA Kit For Measuring Phosphorylated Akt (Ser473) in Human, Mouse and Rat Cell Lysates User Manual (Revised Mar 1, 2012) RayBio Akt (Ser473) ELISA Kit Protocol (Cat#: PEL-Akt-S473-001)

More information

HIGH SCHOOL STUDENT SCIENCE WEEK. St. Paul s Hospital Vancouver, BC

HIGH SCHOOL STUDENT SCIENCE WEEK. St. Paul s Hospital Vancouver, BC HIGH SCHOOL STUDENT SCIENCE WEEK St. Paul s Hospital Vancouver, BC Sponsors 2 AGENDA Location: UBC James Hogg Research Centre (JHRC), St. Paul s Hospital, Room 166 Burrard Building, 1081 Burrard Street,

More information

MEK1/2 (MAPK Kinase) Activity Assay Kit

MEK1/2 (MAPK Kinase) Activity Assay Kit MEK1/2 (MAPK Kinase) Activity Assay Kit For 96 tests Cat. No. SGT440 FOR RESEARCH USE ONLY Not for use in diagnostic procedures USA & Canada Phone: +1(800) 437-7500 Fax: +1 (951) 676-9209 Europe +44 (0)

More information

2.5. Equipment and materials supplied by user PCR based template preparation Influence of temperature on in vitro EGFP synthesis 11

2.5. Equipment and materials supplied by user PCR based template preparation Influence of temperature on in vitro EGFP synthesis 11 Manual 15 Reactions LEXSY in vitro Translation Cell-free protein expression kit based on Leishmania tarentolae for PCR-based template generation Cat. No. EGE-2010-15 FOR RESEARCH USE ONLY. NOT INTENDED

More information

M Keramatipour 2. M Keramatipour 1. M Keramatipour 4. M Keramatipour 3. M Keramatipour 5. M Keramatipour

M Keramatipour 2. M Keramatipour 1. M Keramatipour 4. M Keramatipour 3. M Keramatipour 5. M Keramatipour Molecular Cloning Methods Mohammad Keramatipour MD, PhD keramatipour@tums.ac.ir Outline DNA recombinant technology DNA cloning co Cell based PCR PCR-based Some application of DNA cloning Genomic libraries

More information

TECHNICAL BULLETIN. GenElute mrna Miniprep Kit. Catalog MRN 10 MRN 70

TECHNICAL BULLETIN. GenElute mrna Miniprep Kit. Catalog MRN 10 MRN 70 GenElute mrna Miniprep Kit Catalog Numbers MRN 10, MRN 70 TECHNICAL BULLETIN Product Description The GenElute mrna Miniprep Kit provides a simple and convenient way to purify polyadenylated mrna from previously

More information

Ras activation kit. Catalog Number: ADI-EKS-460. Table of Contents

Ras activation kit. Catalog Number: ADI-EKS-460. Table of Contents Ras activation kit Catalog Number: ADI-EKS-460 Table of Contents Assay Design Page 1 Scientific Overview 1 Precautions 1 Materials Provided 2 Storage of Materials 2 Materials Required but Not Provided

More information

AP Biology Gene Expression/Biotechnology REVIEW

AP Biology Gene Expression/Biotechnology REVIEW AP Biology Gene Expression/Biotechnology REVIEW Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Gene expression can be a. regulated before transcription.

More information

Section IX: Special Applications in Agarose Gels

Section IX: Special Applications in Agarose Gels Section IX: In This Section Amplification of Plasmid cdna Libraries with SeaPrep Agarose 150 Preparing Agarose for use in Cell Culture Applications 152 References 154 149 Section IX: Amplification of Plasmid

More information

Recombinant DNA Technology

Recombinant DNA Technology History of recombinant DNA technology Recombinant DNA Technology (DNA cloning) Majid Mojarrad Recombinant DNA technology is one of the recent advances in biotechnology, which was developed by two scientists

More information

MOLECULAR GENETICS: TRANSFORMATION AND CLONING adapted by Dr. D. L. Vogelien

MOLECULAR GENETICS: TRANSFORMATION AND CLONING adapted by Dr. D. L. Vogelien Introduction MOLECULAR GENETICS: TRANSFORMATION AND CLONING adapted by Dr. D. L. Vogelien The field of molecular genetics has resulted in a number of practical applications that have been of tremendous

More information

SDS-PAGE and Western Blot. Molecular Basis of Evolution

SDS-PAGE and Western Blot. Molecular Basis of Evolution 1 SDS-PAGE and Western Blot Molecular Basis of Evolution Homology high level of DNA and protein sequence similarity due to common ancestry. Evidence Genomes of related organisms are very similar. Even

More information

Cyfra 21-1 IRMA. Product information Information about other products is available at: Userś Manual DE52100

Cyfra 21-1 IRMA. Product information Information about other products is available at:  Userś Manual DE52100 Product information Information about other products is available at: www.demeditec.com Userś Manual Cyfra 21-1 IRMA The CYFRA 21.1 IRMA system provides a direct in vitro quantitative determination of

More information

Roche Molecular Biochemicals Technical Note No. LC 10/2000

Roche Molecular Biochemicals Technical Note No. LC 10/2000 Roche Molecular Biochemicals Technical Note No. LC 10/2000 LightCycler Overview of LightCycler Quantification Methods 1. General Introduction Introduction Content Definitions This Technical Note will introduce

More information

IMMUNOPRECIPITATION (IP)

IMMUNOPRECIPITATION (IP) 1 IMMUNOPRECIPITATION (IP) Overview and Technical Tips 2 CONTENTS 3 7 8 9 12 13 17 18 19 20 Introduction Factors Influencing IP General Protocol Modifications Of IP Protocols Troubleshooting Contact Us

More information

EZ-10 SPIN COLUMN GENOMIC DNA MINIPREPS KIT HANDBOOK

EZ-10 SPIN COLUMN GENOMIC DNA MINIPREPS KIT HANDBOOK EZ-0 SPIN COLUMN GENOMIC DNA MINIPREPS KIT HANDBOOK (Bacteria, Plant, Animal, Blood) Version 8 Rev 05/0/03 EZ-0 Genomic DNA Kit Handbook Table of Contents Introduction Limitations of Use Features Applications

More information

Low cost and non-toxic genomic DNA extraction for use in molecular marker studies.

Low cost and non-toxic genomic DNA extraction for use in molecular marker studies. Low cost and non-toxic genomic DNA extraction for use in molecular marker studies. Version 1.4, February 28 th, 2013. Prepared by Bernhard Hofinger, Owen Huynh and Brad Till. 1. OBJECTIVE To develop and

More information

Guide-it Indel Identification Kit User Manual

Guide-it Indel Identification Kit User Manual Clontech Laboratories, Inc. Guide-it Indel Identification Kit User Manual Cat. No. 631444 (120114) Clontech Laboratories, Inc. A Takara Bio Company 1290 Terra Bella Avenue, Mountain View, CA 94043, USA

More information

Genetics Lecture 21 Recombinant DNA

Genetics Lecture 21 Recombinant DNA Genetics Lecture 21 Recombinant DNA Recombinant DNA In 1971, a paper published by Kathleen Danna and Daniel Nathans marked the beginning of the recombinant DNA era. The paper described the isolation of

More information

NRAS Codon 61 Mutation Analysis Reagents

NRAS Codon 61 Mutation Analysis Reagents NRAS Codon 61 Mutation Analysis Reagents User Manual V1.0 Cat No. GP19 32 reactions 1 CONTENTS Introduction 4 Overview of Mutector TM Assay 5 Materials Provided 6 Materials Required 7 Equipment Required

More information

PARP-1 (cleaved) Human In-Cell ELISA Kit (IR)

PARP-1 (cleaved) Human In-Cell ELISA Kit (IR) ab110215 PARP-1 (cleaved) Human In-Cell ELISA Kit (IR) Instructions for Use For the quantitative measurement of Human PARP-1 (cleaved) concentrations in cultured adherent and suspension cells. This product

More information

For the quantitative detection of human IL6 in serum, plasma, cell culture supernatants and urine.

For the quantitative detection of human IL6 in serum, plasma, cell culture supernatants and urine. m andw da a For the quantitative detection of human IL6 in serum, plasma, cell culture supernatants and urine. general information Catalogue Number Product Name Species cross-reactivity Range (calibration

More information

Orexin A (HUMAN, MOUSE, RAT, PORCINE, OVINE,

Orexin A (HUMAN, MOUSE, RAT, PORCINE, OVINE, Orexin A (HUMAN, MOUSE, RAT, PORCINE, OVINE, BOVINE) Western Blot Kit Protocol (Catalog #WBK-003-30) PHOENIX PHARMACEUTICALS, INC. TABLE OF CONTENTS 1. Kit Contents...2 2. Storage...2 3. Introduction...3

More information

Modified Rapid MAIPA Protocol

Modified Rapid MAIPA Protocol Modified Rapid MAIPA Protocol This method is based on the following publication; K Campbell, K Rishi, G Howkins, D Gilby, R Mushens, C Ghevaert, P Metcalfe, WH Ouwehand, G Lucas. A modified fast MAIPA

More information

PI3 Kinase Assay Kit. Catalog Number KA assays Version: 05. Intended for research use only.

PI3 Kinase Assay Kit. Catalog Number KA assays Version: 05. Intended for research use only. PI3 Kinase Assay Kit Catalog Number KA0904 400 assays Version: 05 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 General Information... 4 Materials Supplied...

More information

Supporting Information

Supporting Information Supporting Information Wiley-VCH 2006 69451 Weinheim, Germany Rolling-circle Amplification of a DNA Nanojunction Chenxiang Lin, Mingyi Xie, Julian J.L. Chen, Yan Liu and Hao Yan A. RCA replication of the

More information

OPPF-UK Standard Protocols: Mammalian Expression

OPPF-UK Standard Protocols: Mammalian Expression OPPF-UK Standard Protocols: Mammalian Expression Joanne Nettleship joanne@strubi.ox.ac.uk Table of Contents 1. Materials... 3 2. Cell Maintenance... 4 3. 24-Well Transient Expression Screen... 5 4. DNA

More information

Bacterial 16S rdna PCR Kit Fast (800)

Bacterial 16S rdna PCR Kit Fast (800) Cat. # RR182A For Research Use Bacterial 16S rdna PCR Kit Fast (800) Product Manual Table of Contents I. Description... 3 II. Components... 3 III. Materials Required but not Provided... 4 IV. Storage...

More information

2054, Chap. 14, page 1

2054, Chap. 14, page 1 2054, Chap. 14, page 1 I. Recombinant DNA technology (Chapter 14) A. recombinant DNA technology = collection of methods used to perform genetic engineering 1. genetic engineering = deliberate modification

More information

M I C R O B I O L O G Y WITH DISEASES BY TAXONOMY, THIRD EDITION

M I C R O B I O L O G Y WITH DISEASES BY TAXONOMY, THIRD EDITION M I C R O B I O L O G Y WITH DISEASES BY TAXONOMY, THIRD EDITION Chapter 7 Microbial Genetics Lecture prepared by Mindy Miller-Kittrell, University of Tennessee, Knoxville The Structure and Replication

More information

Protein A Mag Sepharose Xtra Protein G Mag Sepharose Xtra

Protein A Mag Sepharose Xtra Protein G Mag Sepharose Xtra GE Healthcare Data file 28-9768-1 AA Protein sample preparation Protein A Mag Sepharose Xtra Xtra products are magnetic beads designed for efficient, high capacity small-scale purification/screening of

More information

Immunoglobulins Harry W Schroeder Jr MD PhD

Immunoglobulins Harry W Schroeder Jr MD PhD Immunoglobulins Harry W Schroeder Jr MD PhD Division of Developmental and Clinical Immunology Departments of Medicine, Microbiology, and Genetics University of Alabama at Birmingham Immunoglobulin Has

More information

Positively Charged Membrane

Positively Charged Membrane BIOBOND NYLON MEMBRANES ProductInformation Technical Bulletin No. MB-570 June 1999 Size Quantity Positively Charged Membrane Neutral Membrane 30 cm x 3.5 m 1 roll N4781 N1031 30 cm x 12 m 1 roll N4906

More information

Electronic Supplementary Information Sensitive detection of polynucleotide kinase using rolling circle amplification-induced chemiluminescence

Electronic Supplementary Information Sensitive detection of polynucleotide kinase using rolling circle amplification-induced chemiluminescence Electronic Supplementary Material (ESI) for Chemical Communications. This journal is The Royal Society of Chemistry 2014 Electronic Supplementary Information Sensitive detection of polynucleotide kinase

More information

Human IgG Antigen ELISA Kit

Human IgG Antigen ELISA Kit Human IgG Antigen ELISA Kit Catalog No: IHUIGGKT Lot No: SAMPLE INTENDED USE This human immunoglobulin G antigen assay is intended for the quantitative determination of total human IgG antigen in serum,

More information

Quantitative analysis of PCR fragments with the Agilent 2100 Bioanalyzer. Application Note. Odilo Mueller. Abstract

Quantitative analysis of PCR fragments with the Agilent 2100 Bioanalyzer. Application Note. Odilo Mueller. Abstract Quantitative analysis of PCR fragments with the Agilent 2100 Bioanalyzer Application Note Odilo Mueller Abstract This application note describes how the Agilent Technologies 2100 bioanalyzer can be used

More information

Rapid DNA Ligation & Transformation Kit

Rapid DNA Ligation & Transformation Kit 1 Rapid DNA Ligation & Transformation Kit (#K1432 for 30 reactions) INTRODUCTION The Rapid DNA Ligation & Transformation Kit enables ligation of any type of DNA in 5 minutes at ambient temperature followed

More information

Strep-tag detection in Western blots

Strep-tag detection in Western blots Strep-tag detection in Western blots General protocol for the detection of Strep-tag fusion proteins Last date of revision April 2012 Version PR07-0010 www.strep-tag.com For research use only Important

More information

mcherry Polyclonal Antibody Catalog Number PA Product data sheet

mcherry Polyclonal Antibody Catalog Number PA Product data sheet Website: thermofisher.com Customer Service (US): 1 800 955 6288 ext. 1 Technical Support (US): 1 800 955 6288 ext. 441 mcherry Polyclonal Antibody Catalog Number PA5-34974 Product data sheet Details Size

More information

Discovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A

Discovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A Discovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A Contacts: Marty Simonetti martysimonetti@gmail.com Kirby Alton kirby.alton@abeomecorp.com Rick Shimkets

More information

KPL LumiGLO Reserve Chemiluminescent Substrate

KPL LumiGLO Reserve Chemiluminescent Substrate DESCRIPTION KPL LumiGLO Reserve contains a luminol-based chemiluminescent substrate designed for use with peroxidase-labeled (HRP) reporter molecules. KPL LumiGLO Reserve offers improvements in the way

More information

In vitro Human Umbilical Vein Endothelial Cells (HUVEC) Tube-formation Assay. Josephine MY Ko and Maria Li Lung *

In vitro Human Umbilical Vein Endothelial Cells (HUVEC) Tube-formation Assay. Josephine MY Ko and Maria Li Lung * In vitro Human Umbilical Vein Endothelial Cells (HUVEC) Tube-formation Assay Josephine MY Ko and Maria Li Lung * Clinical Oncology Department, The Univerisity of Hong Kong, Hong Kong, Hong Kong SAR *For

More information

IMGT Locus on Focus. ABC Fax Marie-Paule Lefranc

IMGT Locus on Focus. ABC Fax Marie-Paule Lefranc Exp Clin Immunogenet 1998;15:1 7 Received: January 7, 1998 Marie-Paule Lefranc Laboratoire d ImmunoGénétique Moléculaire, CNRS, Université Montpellier II, Montpellier, France IMGT Locus on Focus A New

More information

PROCEDURE FOR USE NICKEL NTA Magnetic Agarose Beads (5%)

PROCEDURE FOR USE NICKEL NTA Magnetic Agarose Beads (5%) 1 AFFINITY HIS-TAG PURIFICATION PROCEDURE FOR USE NICKEL NTA Magnetic Agarose Beads (5%) DESCRIPTION Nickel NTA Magnetic Agarose Beads are products that allow rapid and easy small-scale purification of

More information